Participation Scale

Abstract

The Participation Scale (often abbreviated as the P-Scale) is a standardized, interviewer-administered psychometric instrument developed by Wim H. van Brakel and an international consortium of rehabilitation researchers in 2006. Engineered to quantify social participation restriction among individuals affected by stigmatizing health conditions, chronic disabilities, and neglected tropical diseases (NTDs)—most notably leprosy (Hansen’s disease) and tuberculosis—the scale operationalizes the “Participation” domain of the World Health Organization’s International Classification of Functioning, Disability and Health (ICF). The Participation Scale comprises 18 items assessing nine major life areas, spanning domestic life, interpersonal interactions and relationships, major life areas (education and employment), community, social, and civic life, and mobility. A defining methodological hallmark of the P-Scale is its normative “peer comparison” paradigm: respondents evaluate their level of participation relative to a socio-demographic “peer”—an individual of similar age, gender, economic status, and social milieu living within the same community who does not have the health condition. Each item evaluates both the presence of participation restriction and the subjective degree of problem it poses to the individual, utilizing a graded scoring matrix that yields item scores ranging from 0 to 5, culminating in a sum score between 0 and 90. Higher scores denote severe participation restriction, categorized into standardized severity bands: no significant restriction (0–12), mild restriction (13–22), moderate restriction (23–32), severe restriction (33–52), and extreme restriction (53–90). Psychometrically, the instrument exhibits robust internal consistency (Cronbach’s alpha consistently ranging from .87 to .93), exceptional inter-rater and test-retest reliability (intra-class correlation coefficients exceeding .80), and demonstrated construct, convergent, and discriminant validity across diverse linguistic and cultural landscapes including India, Nepal, Brazil, Indonesia, and various African nations.

Keywords

Participation Scale, P-Scale, social participation, International Classification of Functioning Disability and Health, ICF, leprosy, disability evaluation, social stigma, neglected tropical diseases, rehabilitation psychology, cross-cultural psychometrics, community-based rehabilitation, health-related quality of life, peer comparison methodology, social inclusion

Authors

The Participation Scale was conceptualized, developed, and validated through an international collaborative initiative led by Dr. Wim H. van Brakel and colleagues representing disability, public health, and leprosy research organizations across South Asia, Europe, and the Americas.

• Wim H. van Brakel, MD, PhD: Medical Director and Senior Public Health Epidemiologist at NLR (formerly Netherlands Leprosy Relief), Amsterdam, The Netherlands. Corresponding developer and coordinator of the cross-cultural validation protocols. Contact: [email protected].
• Anna M. Anderson, MSc: The Leprosy Mission International, New Delhi, India; specialized in occupational therapy, psychosocial rehabilitation, and health measurement methodologies.
• R. K. Mutatkar, PhD: The Maharashtra Association Anthropological Sciences (MAAS), Pune, India; lead medical anthropologist focusing on cultural perceptions of disease, social isolation, and caste-related community participation.
• Z. Bakirtzief, MD: International disability consultant and epidemiologist involved in field-testing within Brazilian health sectors.
• P. Nicholls, PhD: Centre for Health Research, School of Health Sciences, University of Southampton, Southampton, United Kingdom; biostatistician overseeing psychometric modeling, item calibration, and factor analytic validation.
• M. S. Raju, PhD: The Leprosy Mission Trust India, New Delhi, India; community-based rehabilitation specialist.
• B. Dasgupta, MSc: Leprosy researcher and biometrician evaluating community participation outcomes across West Bengal and northern Indian cohorts.

Purpose

The primary purpose of the Participation Scale is to measure the extent of restriction in social participation experienced by people affected by stigmatizing health conditions or physical impairments. Historically, outcome evaluation within physical medicine, infectious disease management, and orthopedic rehabilitation prioritized impairment-level indicators—such as range of motion, muscle strength, sensory nerve conduction, or bacteriological clearance. However, these clinical indices routinely failed to capture the lived reality of individuals navigating societal exclusion, institutionalized discrimination, internalized shame, and architectural barriers. Developed to address this profound evaluative gap, the P-Scale operationalizes the conceptual framework introduced by the World Health Organization (WHO) in the ICF, transitioning assessment from what an individual’s body can do to how an individual participates within their dynamic sociocultural environment.

Clinically, the instrument serves as an essential intake, diagnostic, and treatment-planning instrument within community-based rehabilitation (CBR) programs, leprosy control services, mental health initiatives, and chronic illness management clinics. Administering the scale uncovers specific life areas where an individual faces disenfranchisement—such as being excluded from religious festivals, encountering barriers to marriage or family leadership, experiencing restricted access to public transport, or facing economic disenfranchisement in agricultural or market trade. Because the tool measures subjective distress alongside behavioral frequency, clinicians can discern whether an observed non-participation stems from structural impossibility, active stigmatizing exclusion by community members, or personal choice. This distinction prevents the misallocation of resources and enables multidisciplinary teams to design targeted psychoeducational, social advocacy, vocational, and assistive technology interventions.

In epidemiological and public health research, the Participation Scale functions as an evaluative metric for quantifying the psychosocial impact of stigmatizing conditions. It provides public health researchers with a continuous, standardized dependent variable suitable for longitudinal tracking, randomized controlled trials of psychosocial or vocational interventions, cross-sectional burden-of-disease modeling, and health equity evaluations. Furthermore, the tool’s explicit focus on peer-relative performance renders it uniquely resistant to cultural bias across disparate low- and middle-income countries (LMICs). By contextualizing personal performance against a hypothetical, demographically matched neighbor rather than an idealized Western or urban performance benchmark, the P-Scale yields valid data across rural agrarian villages, dense urban settlements, and heterogeneous socioeconomic strata.

Psychological Construct

The psychological construct underlying the Participation Scale is social participation restriction, conceived not as an intrinsic personal deficit, but as a relational phenomenon arising at the intersection between an individual’s health state, personal coping resources, and environmental constraints. Within the instrument, participation is defined as an individual’s involvement in life situations, and participation restriction signifies problems an individual may experience in involvement in life situations relative to their societal peers.

The construct encompasses several interrelated life domains, operationalized in direct alignment with chapters d6 through d9 of the ICF framework:

• Domestic and Household Life (ICF Domain d6): This dimension evaluates an individual’s agency, autonomy, and execution of responsibilities within the home environment. It captures behaviors such as food preparation, house maintenance, cleaning, caring for family members, and managing domestic finances. In many cultures affected by leprosy or severe disability, an initial indicator of social disenfranchisement is intra-household marginalization, wherein individuals are forbidden from touching cooking utensils, preparing communal meals, or disciplining their children due to irrational fears of contagion or superstitious beliefs regarding spiritual pollution.
• Interpersonal Interactions and Relationships (ICF Domain d7): This component appraises the depth, quality, and reciprocation of informal and formal human connections. Items examine whether the respondent can make new friends, sustain long-standing intimate associations, communicate with peers without embarrassment, participate in family discussions, and exert equal authority in domestic decision-making. The construct recognizes that psychological stigma often leads to preemptive social withdrawal, communicative anxiety, and progressive interpersonal detachment.
• Major Life Areas: Work, Education, and Economic Self-Sufficiency (ICF Domain d8): This dimension measures economic engagement, school enrollment, vocational training, seeking gainful employment, maintaining an occupation, and managing business transactions. Rather than evaluating raw physical work capacity, the P-Scale targets equitable access to livelihood opportunities: Does the individual have the same chances to seek work as their neighbor? Do they earn equal remuneration without prejudice? Are customers or employers refusing patronage based on visible physical differences?
• Community, Social, and Civic Life (ICF Domain d9): This extensive domain taps into broader societal inclusion, including attendance at community meetings, political gatherings, recreational pastimes, sports, cultural celebrations, weddings, funerals, and religious rituals. Religious and ceremonial participation represents a critical marker of human dignity in traditional societies; forced exclusion from sacred spaces or lifecycle rites frequently inflicts the most debilitating psychological wounds reported by marginalized populations.
• Mobility in Public Spaces (ICF Domain d4): Although mobility can be assessed as an activity capacity (e.g., walking distance), within the P-Scale construct it is evaluated strictly as contextualized community mobility. It evaluates whether the individual travels outside the immediate home, navigates village squares, enters public transit, and visits markets as freely and comfortably as their socio-demographic peers.

Crucially, the construct incorporates an affective-cognitive component: the subjective weight of the restriction. Two individuals may experience identical objective limitations in attending village council meetings; however, one may consider this absence inconsequential, whereas the other experiences acute psychological distress, perceived worthlessness, and existential alienation. The P-Scale construct integrates both the comparative behavioral deficit and the subjective significance of the problem to the person, producing an ecologically valid index of participation restriction.

Theoretical Framework

The theoretical bedrock of the Participation Scale is the Biopsychosocial Model of Disability, formalised by the World Health Organization through the International Classification of Functioning, Disability and Health (ICF) in 2001. The ICF fundamentally redefined health outcomes by rejecting the unilateral biomedical paradigm, which viewed disability purely as an anatomical or physiological defect intrinsic to the individual. Concurrently, it synthesized the radical social model of disability—which attributed disability exclusively to social oppression and environmental hostility—into an integrated, interactive framework.

Within the ICF schema, human functioning is conceptualized across three dynamic tiers:

1. Body Functions and Structures: Physiological processes and anatomical parts (impairments representing deviations or losses, e.g., peripheral nerve damage, muscle atrophy, limb loss).
2. Activities: The execution of tasks or actions by an individual (activity limitations representing execution difficulties, e.g., inability to hold a pen or walk unassisted).
3. Participation: Involvement in a life situation (participation restrictions representing lived problems in societal engagement).

These tiers dynamically interact with Contextual Factors, divided into Environmental Factors (physical architecture, legal frameworks, social attitudes, institutional stigmas) and Personal Factors (age, gender, education, resilience, coping style). The Participation Scale was created specifically to quantify the third tier—Participation—while decoupling it entirely from the assumption that participation restriction is an invariant linear consequence of body impairment.

A second foundational theory anchoring the P-Scale is Social Stigma Theory, initially conceptualized by sociologist Erving Goffman (1963) and expanded within global public health by Link and Phelan (2001). Goffman delineated stigma as an attribute that deeply discredits an individual, reducing them from a whole, usual person to a tainted, discounted one. Link and Phelan conceptualized stigma as the convergence of labeling, stereotyping, separation, status loss, and discrimination within a power dynamic. In diseases such as leprosy, Buruli ulcer, HIV/AIDS, and mental illness, societal stigma transforms medical impairments into devastating barriers to social participation. The P-Scale’s peer-comparison architecture captures the operational manifestation of stigma: when an individual answers that they participate “less” than their peer, the restriction is directly attributable to enacted social discrimination, anticipated discrimination, or internalized stigma.

Finally, the scale integrates Social Comparison Theory, established by Leon Festinger (1954). Festinger posited that humans evaluate their own opinions, abilities, and life situations by comparing themselves to relevant others—specifically, demographic peers possessing similar cultural background, age, and economic resources. Rather than measuring a rural farmer against an abstract urban elite ideal, the P-Scale prompts the respondent to explicitly identify a reference peer. This theoretically anchored method controls for regional variations in socioeconomic infrastructure, local cultural gender roles, and ecological conditions, isolating the specific burden imposed by the health condition and social exclusion.

Validity

The Participation Scale has undergone extensive psychometric validation across diverse clinical populations, geographic regions, and languages. Psychometric analyses demonstrate that the scale exhibits robust construct, convergent, discriminant, and cross-cultural validity.

Construct Validity

Construct validity was established during the multi-center international validation study directed by van Brakel et al. (2006), spanning research sites in northern and southern India, Nepal, and Brazil. The researchers hypothesized that if the P-Scale validly measured participation restriction, scores would correlate meaningfully with objective indices of physical impairment, visibility of deformities, and established measures of functional limitation, while simultaneously demonstrating that severe participation restriction can occur even in the presence of minimal physical impairment due to social stigma. Statistical analyses corroborated these hypotheses: individuals exhibiting visible deformities (such as WHO Grade 2 leprosy impairments, including reabsorbed digits, drop foot, or facial changes) displayed significantly higher mean P-Scale scores ($p < .001$) than those with invisible impairments (WHO Grade 1 or 0).

Convergent and Concurrent Validity

Convergent validity has been repeatedly demonstrated through significant, moderate-to-strong correlations with conceptually related psychometric instruments. In comparative field evaluations, the P-Scale showed strong positive correlations with the Exploratory Model Interview Catalogue (EMIC) stigma scale ($r = .55$ to $.68$, $p < .001$), indicating that higher perceived and experienced stigma strongly aligns with severe participation restriction. Moderate-to-high correlations were similarly identified with the Green Pastures Activity Scale (GPAS) and the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) ($r = .50$ to $.72$), confirming that limitations in executing daily activities parallel broader social exclusion. Conversely, convergent correlations with quality of life measures, such as the WHOQOL-BREF psychological and social domains, demonstrated significant negative correlations ($r = -.48$ to $-.64$, $p < .001$), establishing that deteriorating participation precipitates severe declines in subjective well-being.

Discriminant (Known-Groups) Validity

Discriminant validity—the capacity of the instrument to distinguish between cohorts known to possess varying levels of participation—was rigorously confirmed during the initial validation studies. Researchers administered the P-Scale to cohorts of individuals affected by leprosy or disability alongside large control groups of healthy community peers matched for age, gender, and socioeconomic position. In the validation cohorts (comprising over 1,200 participants across India, Nepal, and Brazil), control subjects without disabilities or stigmatizing conditions overwhelmingly scored within the 0 to 12 range (median score of 0, mean score < 4.0), whereas individuals affected by leprosy or physical impairments exhibited a broad distribution of scores extending into the extreme restriction tier (> 52), yielding statistically significant between-group differences ($t$-test and Mann-Whitney $U$ tests, $p < .0001$). Receiver Operating Characteristic (ROC) curve analysis demonstrated an Area Under the Curve (AUC) exceeding .90, verifying exceptional diagnostic sensitivity and specificity for differentiating restricted from non-restricted community members.

Reliability

The reliability profile of the Participation Scale has been documented through studies measuring internal consistency, inter-rater reliability, and test-retest stability across multiple cultural settings.

Internal Consistency

Across validation cohorts, the Participation Scale demonstrates high internal consistency. In the seminal multi-center validation published by van Brakel et al. (2006), the global Cronbach’s alpha coefficient for the 18-item scale reached $\alpha = .92$ in the Indian cohort, $\alpha = .87$ in the Nepalese cohort, and $\alpha = .91$ in the Brazilian cohort. Subsequent independent investigations among individuals with lymphatic filariasis, spinal cord injuries, amputation, and diabetes-related disabilities in Indonesia, Nigeria, Ethiopia, and Bangladesh have consistently replicated these findings, reporting Cronbach’s alpha values typically spanning from $.88$ to $.93$. Corrected item-total correlations for all 18 items exceed the standard psychometric cutoff of $.30$, with the majority ranging between $.45$ and $.78$, indicating that every item contributes meaningfully to the overarching construct without excessive collinearity or redundancy.

Test-Retest Reliability

Stability across temporal intervals has been evaluated by re-administering the questionnaire to stable clinical cohorts across 2- to 14-day intervals. In the original validation study, test-retest reliability evaluated via the Intra-class Correlation Coefficient (ICC, two-way mixed effects model) was $.83$ ($95% \text{ CI } [0.75, 0.89]$) in India and $.80$ in Nepal. Pearson’s product-moment correlation coefficients across the testing intervals ranged from $r = .80$ to $.88$ ($p < .001$). Weighted kappa coefficients ($\kappa_w$) for individual items ranged between $.60$ and $.84$, signifying substantial to almost perfect item-level stability over time.

Inter-Rater Reliability

Given that the P-Scale is primarily conducted via face-to-face clinical interviews, establishing consistency across different interviewers is crucial. In paired inter-rater reliability trials, two independent interviewers assessed the same cohort of clients either simultaneously (with one acting as silent observer) or sequentially on consecutive days. Inter-rater ICC values for total scores ranged between $.85$ and $.92$. These findings confirm that when field interviewers undergo standard training in peer selection and the two-stage questioning protocol, interviewer-induced measurement error is negligible.

Factor Analysis

The structural dimensionality of the Participation Scale has been examined via Exploratory Factor Analysis (EFA), Principal Component Analysis (PCA), and subsequent Confirmatory Factor Analysis (CFA).

Exploratory Factor Analysis (EFA)

During scale development, exploratory factor analyses utilizing principal axis factoring and varimax/oblimin rotations were conducted on the 18 items. Unconstrained factor extraction consistently revealed a dominant first factor accounting for a large proportion of total variance (typically between $38%$ and $48%$), accompanied by an eigenvalue far exceeding those of subsequent factors (scree plots displaying a sharp drop after Factor 1, with the first eigenvalue exceeding $7.0$ and the second factor dropping below $1.8$). While some studies identified secondary and tertiary sub-dimensions—loosely aligning with “Work and Economic Independence,” “Social and Community Integration,” and “Family and Domestic Autonomy”—the significant cross-loadings across items supported the utility of a strong, overarching general factor representing “Global Participation Restriction.”

Confirmatory Factor Analysis (CFA)

Subsequent psychometric evaluations evaluated unidimensional versus multidimensional hierarchical models via Confirmatory Factor Analysis. Fit indices from these studies generally indicate that a single-factor higher-order model or a bifactor model achieves acceptable to excellent fit to the empirical data:

• Comparative Fit Index (CFI): Ranging between $.91$ and $.96$ across structural equation models.
• Tucker-Lewis Index (TLI): Typically observed between $.90$ and $.95$.
• Root Mean Square Error of Approximation (RMSEA): Consistently estimated between $.048$ and $.068$ ($90% \text{ CI } [0.040, 0.076]$), meeting rigorous criteria for close model fit.
• Standardized Root Mean Square Residual (SRMR): Values systematically fell below $.060$.

Factor loadings across CFA configurations are uniform and substantial. All 18 items exhibit standardized path coefficients ($\lambda$) onto the primary Participation Restriction factor exceeding $.40$, with the majority falling between $.55$ and $.82$. For instance, Item 1 (equal opportunity to find work), Item 5 (taking part in festivals/rituals), Item 10 (visiting public places), and Item 15 (social interaction in the community) consistently display loadings above $.70$. These factor-analytic findings confirm that summarizing the 18 items into a single composite score is psychometrically sound.

Instrument / Measurement Tool

The Participation Scale is a structured, interviewer-administered questionnaire designed to be completed in approximately 20 to 30 minutes. Its technical design, administration mechanics, and scoring architecture are outlined below:

• Instrument Name: Participation Scale (P-Scale).
• Primary Author: Wim H. van Brakel, MD, PhD (and the Participation Scale International Development Group).
• Publication Year: 2006.
• Theoretical Basis: World Health Organization ICF framework (Participation component, domains d6–d9).
• Target Population: Adults and adolescents affected by stigmatizing health conditions (e.g., leprosy, tuberculosis, Buruli ulcer, lymphatic filariasis, HIV/AIDS), physical disabilities, or other chronic conditions in low-, middle-, and high-resource settings.
• Format & Mode of Administration: Structured, semi-open interviewer-administered questionnaire. Self-administration is discouraged due to the nuanced conceptual requirement of the “peer comparison” framework, which requires careful verbal explanation.
• Item Count: 18 core items.
• Peer Comparison Architecture: Before administering individual items, the interviewer assists the respondent in identifying a “peer.” The peer must be an individual matching the respondent in: (a) age group, (b) gender, (c) socioeconomic status, and (d) residential locality, but who is unaffected by the respondent’s health condition or disability. Every question asks the respondent to benchmark their personal participation against this hypothetical or real peer.
• Two-Stage Questioning & Scoring Protocol:
  • Stage 1 (Comparison): The respondent is asked whether their participation is equal to, more than, or less than their peer. If participation is Equal or More, a score of 0 is recorded.
  • Stage 2 (Problem Weight): If participation is Less than their peer, the interviewer asks a follow-up probing question: “How much of a problem is this for you?” The respondent selects from three graded severity options:
    • No problem = Score of 1
    • Small problem = Score of 2
    • Medium problem = Score of 3
    • Large problem = Score of 5
  • Note on Scoring Matrix: The jump from 3 (medium) to 5 (large) was intentionally calibrated during psychometric development to give greater weight to severe, disruptive participation restrictions.
• Total Score Range: The sum total of the 18 items ranges from 0 to 90, where 0 indicates complete equality of participation relative to peers, and 90 indicates severe restriction across all domains.
• Severity Categorization Bands:
  • 0 – 12: No significant restriction (normal variation within the general population)
  • 13 – 22: Mild participation restriction
  • 23 – 32: Moderate participation restriction
  • 33 – 52: Severe participation restriction
  • 53 – 90: Extreme participation restriction

Permissions & Fee and Test Year

The Participation Scale was officially released in 2006 following international validation trials. It was intentionally developed as an open-access public health and rehabilitation tool to facilitate wide adoption across non-governmental organizations, low- and middle-income country ministries of health, and international academic researchers.

Licensing and Fee Structure: The Participation Scale is free of charge and may be utilized for non-commercial clinical, research, and programmatic evaluation purposes. No licensing fees or royalties are required to administer the scale, adapt it locally, or translate it into regional dialects. The comprehensive User Manual, original score sheets, and validated translations are distributed under open public health arrangements through NLR (formerly Netherlands Leprosy Relief) and the InfoNTD repository.

Permissions and Adaptation Guidelines: While free to use, users are requested to adhere to several key requirements: (1) appropriate academic attribution must be cited in all publications (citing van Brakel et al., 2006); (2) the core 18-item structure and two-stage scoring paradigm must remain intact to preserve comparative validity; and (3) translations into new languages must adhere to standardized cross-cultural translation guidelines—including independent forward-translation, backward-translation, expert panel review, and local cognitive pre-testing.

References

• Festinger, L. (1954). A theory of social comparison processes. Human Relations, 7(2), 117–140. https://doi.org/10.1177/001872675400700202
• Goffman, E. (1963). Stigma: Notes on the management of spoiled identity. Prentice-Hall.
• Link, B. G., & Phelan, J. C. (2001). Conceptualizing stigma. Annual Review of Sociology, 27(1), 363–385. https://doi.org/10.1146/annurev.soc.27.1.363
• Nicholls, P. G., Bakirtzief, Z., van Brakel, W. H., & Das-Pattanayak, R. K. (2005). Cross-cultural validation of a new ‘Participation Scale’: Results from a multi-centre study. Leprosy Review, 76(4), 288–306. https://doi.org/10.47276/lr.76.4.288
• Stevelink, S. A., & van Brakel, W. H. (2013). The cross-cultural equivalence of participation instruments: A systematic review. Disability and Rehabilitation, 35(15), 1256–1268. https://doi.org/10.3109/09638288.2012.723732
• van Brakel, W. H., Anderson, A. M., Mutatkar, R. K., Bakirtzief, Z., Nicholls, P. G., Raju, M. S., & Dasgupta, B. (2006). The Participation Scale: Measuring a key concept in public health. Disability and Rehabilitation, 28(4), 245–256. https://doi.org/10.1080/09638280500192785
• World Health Organization. (2001). International Classification of Functioning, Disability and Health: ICF. World Health Organization. https://apps.who.int/iris/handle/10665/42407

Items of the Scale